China's Beijing COTEC New Technologies Cooperation reports good salesof its Cotecxin antimalarial drug in Africa, particularly in Kenya, notes ChinaAfrica. COTEC has gradually developed a marketing network by acquainting doctors and pharmacists with Cotecxin. 20% of all doctors in Kenya have attended its introduction seminars.
Doctors and retailers who have used or sold Cotecxin have reportedly been rewarded with bonuses or price cuts. To improve sales, the company has developed small doses for children, powder form doses and packaging in Swahili.
- The Shanghai authorities are to give funds and preferential treatment to local drug firms to help them compete against multinationals locally. But, they add, local firms must compete internationally with the multinationals, reports the CDBW.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze